Second Quarter 2020 Results Reported by Amphenol Corporation

WALLINGFORD, Conn.–(BUSINESS WIRE)–Amphenol Corporation (NYSE: APH) reported today GAAP diluted Earnings Per Share (“EPS”) for the second quarter 2020 of $0.85 compared to $0.93 for the comparable 2019 period. GAAP diluted EPS for the second quarter 2020 included an excess tax benefit of $12 million ($0.04 per share) related to stock options exercised during the quarter. Second quarter 2019 GAAP diluted EPS included an excess tax benefit of $13 million ($0.04 per share) related to stock options exercised during the quarter, partially offset by acquisition-related costs of $9 million ($0.03 per share). Excluding the effect of these items, Adjusted Diluted EPS1 for the second quarter 2020 was $0.81 compared to $0.92 for the second quarter 2019. Sales for the second quarter 2020 were $1.987 billion compared to $2.015 billion for the comparable 2019 period. Currency translation had the effect of decreasing sales by $22 million in the second quarter 2020 compared to the 2019 period.

For the six months ended June 30, 2020, GAAP Diluted EPS was $1.64, compared to $1.80 for the comparable 2019 period. GAAP Diluted EPS for the six months ended June 30, 2020 included (i) a discrete tax benefit of $20 million ($0.06 per share) related to the settlements of refund claims in certain non-U.S. jurisdictions and the resulting adjustments to deferred taxes and (ii) an excess tax benefit of $17 million ($0.06 per share) related to stock options exercised during the period. The comparable 2019 period included acquisition-related costs of $25 million ($0.07 per share), partially offset by an excess tax benefit of $20 million ($0.06 per share) related to stock options exercised during the period. Excluding the effect of these items, Adjusted Diluted EPS for the six months ended June 30, 2020 and 2019 was $1.52 and $1.81, respectively. Sales for the six months ended June 30, 2020 were $3.850 billion compared to $3.974 billion for the 2019 period. Currency translation had the effect of decreasing sales by $40 million for the first six months of 2020 compared to the 2019 period.

Amphenol President and Chief Executive Officer, R. Adam Norwitt, stated, “The COVID-19 pandemic continued to negatively impact our business in the second quarter 2020 as certain customers experienced reduced demand and several of our facilities faced production constraints related to government restrictions adopted to mitigate the spread of the virus. Amidst these very challenging conditions, our team drove results that exceeded our expectations, all while prioritizing the safety and health of our employees worldwide.”

“We are pleased to have closed the second quarter 2020 with sales and Adjusted Diluted EPS reaching $1.987 billion and $0.81, respectively. Compared to the second quarter 2019, sales decreased by just 1%, primarily driven by the continued severe slowdown in the automotive and commercial air markets largely offset by strong growth in the information technology and data communications, mobile devices and industrial markets.”

“It is extremely rewarding that even in this most challenging environment the Company’s experienced management team continues to react quickly to ensure that profitability, cash flow and liquidity remain strong. Despite facing significant cost pressures related to the COVID-19 pandemic, second quarter operating margins improved sequentially to 18.0% and operating cash flow was $368 million, a clear confirmation of the quality of the Company’s earnings. The Company continues to deploy its financial strength in a variety of ways to increase shareholder value. To that end, while the Company did not make any purchases under its stock buyback program in the second quarter, the Company paid dividends of $74 million and paid down $1.3 billion of debt, resulting in $1.3 billion of cash and cash equivalents on hand at the end of the quarter.”

“The Company continues to expand its growth opportunities through a deep commitment to developing enabling technologies for customers in all markets, an ongoing strategy of market and geographic diversification and an active and successful acquisition program. As part of that program, we are excited to have acquired Onanon, Inc. (“Onanon”) in the last week. Based in California, Onanon designs and manufactures a wide array of connectors and cable assemblies for customers in the industrial market, with a primary focus on medical applications. With annual sales of approximately $20 million, this acquisition strengthens the Company’s global capabilities and enhances our product offerings, while adding an outstanding management team to the Amphenol family.”

“As we look ahead, the continued and significant economic and public health uncertainties created by the COVID-19 pandemic make it difficult to accurately forecast our performance in the second half of 2020. Accordingly, we are once again not providing full-year sales and EPS guidance. However, considering the current demand environment and assuming no new material disruptions from the pandemic as well as constant exchange rates, for the third quarter 2020, we expect sales to be in the range of $1.960 billion to $2.000 billion and Adjusted Diluted EPS in the range of $0.84 to $0.86.”

“Despite the significant challenges posed by the current environment, we are encouraged by the platform of strength that has been created by the Company’s consistent and superior performance. We remain confident in the ability of our outstanding entrepreneurial management team to dynamically adjust to changing market conditions, to capitalize on the wide array of growth opportunities that arise even in times of crisis and to continue to generate strong financial performance. Most importantly, I am truly grateful to our employees around the world for their incredible efforts to protect the safety and health of our entire team and support our local communities, all while ensuring that our customers have a ready supply of our high-technology interconnect products, many of which are being used in support of the fight against the COVID-19 crisis.”

The Company will host a conference call to discuss its second quarter results at 1:00 PM (EDT) Wednesday, July 22, 2020. The toll-free dial-in number to participate in this call is 888-455-0949; International dial-in number is +1-773-799-3973; Passcode: LAMPO. There will be a replay available until 11:59 PM (EDT) on Saturday, August 22, 2020. The replay numbers are toll free 800-835-4610; International toll number is +1-203-369-3352; Passcode: 7183.

A live broadcast as well as a replay can be accessed through the Investor Relations section of the company’s website at https://investors.amphenol.com.

Amphenol Corporation is one of the world’s largest designers, manufacturers and marketers of electrical, electronic and fiber optic connectors and interconnect systems, antennas, sensors and sensor-based products and coaxial and high-speed specialty cable. Amphenol designs, manufactures and assembles its products at facilities in the Americas, Europe, Asia, Australia and Africa and sells its products through its own global sales force, independent representatives and a global network of electronics distributors. Amphenol has a diversified presence as a leader in high-growth areas of the interconnect market including: Automotive, Broadband Communications, Commercial Aerospace, Industrial, Information Technology and Data Communications, Military, Mobile Devices and Mobile Networks.

Forward-Looking Statements

This press release may include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which relate to future events and are subject to risks and uncertainties. The forward-looking statements, which address the Company’s expected business and financial performance and financial condition, among other matters, may contain words or phrases such as: “believe,” “continue,” “expect,” “look ahead,” “predict,” or “will,” and other words and phrases of similar meaning. Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements about expected earnings, revenues, growth, liquidity or other financial matters, together with any statements related in any way to the COVID-19 pandemic including its impact on the Company. Although the Company believes the expectations reflected in such forward-looking statements including regarding the third quarter 2020 sales and Adjusted Diluted EPS expectations are based upon reasonable assumptions, the expectations may not be attained or there may be material deviation. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date on which they are made.

Factors that could cause actual results to differ materially from these forward-looking statements, include, but are not limited to, the following: future risks and existing uncertainties associated with the COVID-19 pandemic, which continues to have an adverse impact on our operations including, depending on the specific location, government actions that limit our ability to operate certain of our facilities at full capacity or at all, government actions that limit our ability to adjust certain costs, travel restrictions, “work-from-home” orders and the gradual transition back to the workplace, limited availability of our workforce in some locations, supplier constraints, supply-chain interruptions, logistics challenges and limitations, and reduced demand from certain customers; uncertainties associated with a protracted economic slowdown that could negatively affect the financial condition of our customers; uncertainties and volatility in the global capital markets; political, economic, military and other risks in countries outside of the United States; the impact of general economic conditions, geopolitical conditions and U.S. trade policies, legislation, trade disputes, treaties and tariffs, including those affecting China, on the Company’s business operations; risks associated with the improper conduct by any of our employees, customers, suppliers, distributors or any other business partners which could impair our business reputation and financial results and could result in our non-compliance with anti-corruption laws and regulations of the U.S. government and various foreign jurisdictions; changes in exchange rates of the various currencies in which the Company conducts business; the Company’s ability to obtain a consistent supply of materials, at stable pricing levels; the Company’s dependence on sales to the communications industry, which markets are dominated by large manufacturers and operators who regularly exert significant pressure on suppliers, including the Company; changes in defense expenditures in the military market, including the impact of reductions or changes in the defense budgets of U.S. and foreign governments; the Company’s ability to compete successfully on the basis of technology innovation, product quality and performance, price, customer service and delivery time; the Company’s ability to continue to conceive, design, manufacture and market new products and upon continuing market acceptance of its existing and future product lines; difficulties and unanticipated expenses in connection with purchasing and integrating newly acquired businesses, including the potential for the impairment of goodwill and other intangible assets; events beyond the Company’s control that could lead to an inability to meet its financial covenants which could result in a default under the Company’s revolving credit facility; the Company’s ability to access the capital markets on favorable terms, including as a result of significant deterioration of general economic or capital market conditions, or as a result of a downgrade in the Company’s credit rating; changes in interest rates; government contracting risks that the Company may be subject to, including laws and regulations governing performance of U.S. government contracts and related risks associated with conducting business with the U.S. government or its suppliers (both directly and indirectly); governmental export and import controls that certain of our products may be subject to, including export licensing, customs regulations, economic sanctions or other laws; cybersecurity threats or incidents that could arise on our information technology systems which could disrupt business operations and adversely impact our reputation and operating results and potentially lead to litigation and/or governmental investigations; changes in fiscal and tax policies, audits and examinations by taxing authorities, laws, regulations and guidance in the United States and foreign jurisdictions, including related interpretations of certain provisions of the Tax Cuts and Jobs Act of 2017; any difficulties in protecting the Company’s intellectual property rights; and litigation, customer claims, product recalls, governmental investigations, criminal liability or environmental matters. In addition, the extent to which the COVID-19 pandemic will continue to impact our business and financial results going forward will be dependent on future developments such as the length and severity of the crisis, the potential resurgence of the crisis, future government actions in response to the crisis and the overall impact of the COVID-19 pandemic on the global economy and capital markets, among many other factors, all of which remain highly uncertain and unpredictable.

A further description of these uncertainties and other risks can be found in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019, Quarterly Reports on Form 10-Q and the Company’s other reports filed with the Securities and Exchange Commission. These or other uncertainties may cause the Company’s actual future results to be materially different from those expressed in any forward-looking statements. The Company undertakes no obligation to update or revise any forward-looking statements except as required by law.

Non-GAAP Financial Measures

The financial statements included within this press release are prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). This press release also contains certain non-GAAP financial information, including Adjusted Operating Income, Adjusted Operating Margin, Adjusted Net Income attributable to Amphenol Corporation, Adjusted Effective Tax Rate and Adjusted Diluted EPS (collectively, “non-GAAP financial measures”), which are intended to supplement the reported GAAP results. Management utilizes these non-GAAP financial measures as part of its internal reviews for purposes of monitoring, evaluating and forecasting the Company’s financial performance, communicating operating results to the Company’s Board of Directors and assessing related employee compensation measures. Management believes that such non-GAAP financial measures may be helpful to investors in assessing the Company’s overall financial performance, trends and period-over-period comparative results. Non-GAAP financial measures discussed within this press release exclude income and expenses that are not directly related to the Company’s operating performance during the periods presented. Items excluded in the presentation of the non-GAAP financial measures in any period may consist of, without limitation, acquisition-related expenses, refinancing-related costs and certain discrete tax items including but not limited to the excess tax benefits related to stock-based compensation as well as the impact of significant changes in tax law. Reconciliations of non-GAAP financial measures to the most directly comparable GAAP financial measures are included at the end of this press release. However, such non-GAAP financial measures should not be considered in isolation, as a substitute for or superior to the related GAAP financial measures. In addition, these non-GAAP financial measures are not necessarily the same or comparable to similar measures presented by other companies, as such measures may be calculated differently or may exclude different items. The non-GAAP financial measures are defined within the “Supplemental Financial Information” table at the end of this press release and should be read in conjunction with the Company’s financial statements presented in accordance with GAAP.

1 All referenced non-GAAP financial measures are defined in the tables at the end of this press release.

AMPHENOL CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(Unaudited)

(dollars and shares in millions, except per share data)

Three Months Ended

Six Months Ended

June 30,

June 30,

2020

2019

2020

2019

Net sales

$

1,987.5

$

2,015.3

$

3,849.5

$

3,973.8

Cost of sales

1,383.7

1,367.7

2,685.9

2,698.4

Gross profit

603.8

647.6

1,163.6

1,275.4

Acquisition-related expenses

8.9

25.4

Selling, general and administrative expenses

246.4

239.2

489.3

474.3

Operating income

357.4

399.5

674.3

775.7

Interest expense

(30.2

)

(30.0

)

(59.0

)

(59.7

)

Other income, net

1.3

0.1

2.4

3.1

Income before income taxes

328.5

369.6

617.7

719.1

Provision for income taxes (1)

(68.0

)

(78.7

)

(114.0

)

(158.3

)

Net income

260.5

290.9

503.7

560.8

Less: Net income attributable to noncontrolling interests

(2.8

)

(2.5

)

(3.9

)

(4.8

)

Net income attributable to Amphenol Corporation

$

257.7

$

288.4

$

499.8

$

556.0

Net income per common share – Basic

$

0.87

$

0.97

$

1.68

$

1.87

Weighted average common shares outstanding – Basic

296.6

298.0

297.0

298.1

Net income per common share – Diluted (2)

$

0.85

$

0.93

$

1.64

$

1.80

Weighted average common shares outstanding – Diluted

304.0

308.7

305.2

308.7

_______________________________

Note 1

Provision for income taxes for the three months ended June 30, 2020 and 2019 includes excess tax benefits related to stock-based compensation of $12.4 million ($0.04 per share) and $12.9 million ($0.04 per share), respectively. Provision for income taxes for the six months ended June 30, 2020 and 2019 includes excess tax benefits related to stock-based compensation of $17.4 million ($0.06 per share) and $19.7 million ($0.06 per share), respectively. Provision for income taxes for the six months ended June 30, 2020 also includes a discrete tax benefit of $19.9 million ($0.06 per share) related to the settlements of refund claims in certain non-U.S. jurisdictions and the resulting adjustments to deferred taxes.

Note 2

Net income per share for the three months ended June 30, 2020 includes the excess tax benefits related to stock-based compensation discussed in Note 1. Net income per share for the three months ended June 30, 2019 includes the excess tax benefits related to stock-based compensation discussed in Note 1, partially offset by acquisition-related expenses of $8.9 million ($7.8 million after-tax or $0.03 per share) comprising of external transaction costs of $5.7 million and the amortization of $3.2 million related to the value associated with acquired backlog from an acquisition that closed in the second quarter of 2019.

Net income per share for the six months ended June 30, 2020 includes (i) the discrete tax benefit and (ii) excess tax benefits related to stock-based compensation, each discussed in Note 1. Net income per share for the six months ended June 30, 2019 includes acquisition-related expenses of $25.4 million ($21.0 million after-tax or $0.07 per share) comprising of the amortization of $15.7 million related to the value associated with acquired backlog primarily from the SSI acquisition, as well as external transaction costs of $9.7 million, partially offset by the excess tax benefits related to stock-based compensation discussed in Note 1.

Excluding these effects, Adjusted Diluted EPS, a non-GAAP financial measure which is defined and reconciled to its most comparable GAAP financial measure in this press release, was $0.81 and $0.92 for the three months ended June 30, 2020 and 2019, respectively, and $1.52 and $1.81 for the six months ended June 30, 2020 and 2019, respectively.

AMPHENOL CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

(dollars in millions)

June 30,

December 31,

2020

2019

ASSETS

Current Assets:

Cash and cash equivalents

$

1,288.3

$

891.2

Short-term investments

25.7

17.4

Total cash, cash equivalents and short-term investments

1,314.0

908.6

Accounts receivable, less allowance for doubtful accounts of $43.6 and $33.6, respectively

1,658.3

1,736.4

Inventories

1,361.9

1,310.1

Prepaid expenses and other current assets

283.8

256.1

Total current assets

4,618.0

4,211.2

Property, plant and equipment, less accumulated depreciation of $1,578.7 and $1,487.2, respectively

1,001.7

999.0

Goodwill

4,867.0

4,867.1

Other intangible assets, net

416.2

442.0

Other long-term assets

301.0

296.2

$

11,203.9

$

10,815.5

LIABILITIES & EQUITY

Current Liabilities:

Accounts payable

$

928.0

$

866.8

Accrued salaries, wages and employee benefits

179.0

171.8

Accrued income taxes

119.1

127.9

Accrued dividends

74.6

74.4

Other accrued expenses

482.2

488.5

Current portion of long-term debt

2.3

403.3

Total current liabilities

1,785.2

2,132.7

Long-term debt, less current portion

3,763.8

3,203.4

Accrued pension and postretirement benefit obligations

187.3

198.8

Deferred income taxes

270.7

260.4

Other long-term liabilities

396.6

424.0

Equity:

Common stock

0.3

0.3

Additional paid-in capital

1,834.5

1,683.3

Retained earnings

3,419.4

3,348.4

Treasury stock, at cost

(21.0

)

(70.8

)

Accumulated other comprehensive loss

(494.6

)

(430.9

)

Total shareholders’ equity attributable to Amphenol Corporation

4,738.6

4,530.3

Noncontrolling interests

61.7

65.9

Total equity

4,800.3

4,596.2

$

11,203.9

$

10,815.5

AMPHENOL CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW

(Unaudited)

(dollars in millions)

Six Months Ended

June 30,

2020

2019

Cash from operating activities:

Net income

$

503.7

$

560.8

Adjustments to reconcile net income to cash provided by operating activities:

Depreciation and amortization

143.6

163.4

Stock-based compensation expense

32.0

29.8

Deferred income tax provision (benefit)

5.1

(23.6

)

Net change in components of working capital

70.8

(66.6

)

Net change in other long-term assets and liabilities

(2.8

)

2.2

Net cash provided by operating activities

752.4

666.0

Cash from investing activities:

Capital expenditures

(128.3

)

(149.9

)

Proceeds from disposals of property, plant and equipment

1.9

5.5

Purchases of short-term investments

(49.1

)

(36.9

)

Sales and maturities of short-term investments

40.3

34.4

Acquisitions, net of cash acquired

(16.5

)

(756.2

)

Net cash used in investing activities

(151.7

)

(903.1

)

Cash from financing activities:

Proceeds from issuance of senior notes

942.3

499.5

Repayments of senior notes and other long-term debt

(401.3

)

(757.8

)

Borrowings under credit facilities

1,567.4

Repayments under credit facilities

(1,568.1

)

(Repayments) borrowings under commercial paper programs, net

(385.2

)

667.5

Payment of costs related to debt financing

(8.7

)

(7.2

)

Payment of acquisition-related contingent consideration

(75.0

)

Proceeds from exercise of stock options

152.5

113.5

Distributions to and purchases of noncontrolling interests

(9.7

)

(24.6

)

Purchase of treasury stock

(257.2

)

(408.7

)

Dividend payments

(148.4

)

(137.2

)

Net cash used in financing activities

(191.4

)

(55.0

)

Effect of exchange rate changes on cash and cash equivalents

(12.2

)

(4.9

)

Net change in cash and cash equivalents

397.1

(297.0

)

Cash and cash equivalents balance, beginning of period

891.2

1,279.3

Cash and cash equivalents balance, end of period

$

1,288.3

$

982.3

Cash paid for:

Interest

$

47.2

$

57.8

Income taxes, net

141.6

241.7

AMPHENOL CORPORATION

SEGMENT INFORMATION

(Unaudited)

(dollars in millions)

Three Months Ended

Six Months Ended

June 30,

June 30,

2020

2019

2020

2019

Net sales:

Interconnect Products and Assemblies

$

1,898.5

$

1,925.6

$

3,677.5

$

3,788.3

Cable Products and Solutions

89.0

89.7

172.0

185.5

Consolidated Net sales

$

1,987.5

$

2,015.3

$

3,849.5

$

3,973.8

Operating income:

Interconnect Products and Assemblies

$

379.5

$

428.4

$

719.2

$

838.5

Cable Products and Solutions

8.4

8.7

14.8

19.1

Stock-based compensation expense

(16.6

)

(15.4

)

(32.0

)

(29.8

)

Acquisition-related expenses

(8.9

)

(25.4

)

Other operating expenses

(13.9

)

(13.3

)

(27.7

)

(26.7

)

Consolidated Operating income

$

357.4

$

399.5

$

674.3

$

775.7

Operating margin (%):

Interconnect Products and Assemblies

20.0

%

22.2

%

19.6

%

22.1

%

Cable Products and Solutions

9.4

%

9.7

%

8.6

%

10.3

%

Stock-based compensation expense

-0.8

%

-0.8

%

-0.8

%

-0.7

%

Acquisition-related expenses

0.0

%

-0.5

%

0.0

%

-0.7

%

Other operating expenses

-0.7

%

-0.7

%

-0.7

%

-0.7

%

Consolidated Operating margin (%)

18.0

%

19.8

%

17.5

%

19.5

%

AMPHENOL CORPORATION

SUPPLEMENTAL FINANCIAL INFORMATION

RECONCILIATIONS OF GAAP TO NON-GAAP FINANCIAL MEASURES

(Unaudited)

(dollars in millions, except per share data)

Management utilizes the non-GAAP financial measures defined below as part of its internal reviews for purposes of monitoring, evaluating and forecasting the Company’s financial performance, communicating operating results to the Company’s Board of Directors and assessing related employee compensation measures. Management believes that such non-GAAP financial measures may be helpful to investors in assessing the Company’s overall financial performance, trends and period-over-period comparative results. The following non-GAAP financial measures exclude income and expenses that are not directly related to the Company’s operating performance during the periods presented. Items excluded in the presentation of these non-GAAP financial measures in any period may consist of, without limitation, acquisition-related expenses, refinancing-related costs, and certain discrete tax items including but not limited to (i) the excess tax benefits related to stock-based compensation and (ii) the impact of significant changes in tax law. The following non-GAAP financial information is included for supplemental purposes only and should not be considered in isolation, as a substitute for or superior to the related U.S. GAAP financial measures. In addition, these non-GAAP financial measures are not necessarily the same or comparable to similar measures presented by other companies, as such measures may be calculated differently or may exclude different items. Such non-GAAP financial measures should be read in conjunction with the Company’s financial statements presented in accordance with U.S. GAAP.

The following are reconciliations of non-GAAP financial measures to the most directly comparable U.S. GAAP financial measures for the periods presented:

Three Months Ended June 30,

2020

2019

Net Income

Net Income

attributable

Effective

attributable

Effective

Operating

Operating

to Amphenol

Tax

Diluted

Operating

Operating

to Amphenol

Tax

Diluted

Income

Margin (1)

Corporation

Rate (1)

EPS

Income

Margin (1)

Corporation

Rate (1)

EPS

Reported (GAAP)

$

357.4

18.0

%

$

257.7

20.7

%

$

0.85

$

399.5

19.8

%

$

288.4

21.3

%

$

0.93

Acquisition-related expenses

8.9

0.5

7.8

(0.3

)

0.03

Excess tax benefits related to stock-based compensation

(12.4

)

3.8

(0.04

)

(12.9

)

3.5

(0.04

)

Adjusted (non-GAAP) (2)

$

357.4

18.0

%

$

245.3

24.5

%

$

0.81

$

408.4

20.3

%

$

283.3

24.5

%

$

0.92

Six Months Ended June 30,

2020

2019

Net Income

Net Income

attributable

Effective

attributable

Effective

Operating

Operating

to Amphenol

Tax

Diluted

Operating

Operating

to Amphenol

Tax

Diluted

Income

Margin (1)

Corporation

Rate (1)

EPS

Income

Margin (1)

Corporation

Rate (1)

EPS

Reported (GAAP)

$

674.3

17.5

%

$

499.8

18.5

%

$

1.64

$

775.7

19.5

%

$

556.0

22.0

%

$

1.80

Acquisition-related expenses

25.4

0.7

21.0

(0.2

)

0.07

Excess tax benefits related to stock-based compensation

(17.4

)

2.8

(0.06

)

(19.7

)

2.7

(0.06

)

Discrete tax item

(19.9

)

3.2

(0.06

)

Adjusted (non-GAAP) (2)

$

674.3

17.5

%

$

462.5

24.5

%

$

1.52

$

801.1

20.2

%

$

557.3

24.5

%

$

1.81

______________________________

(1)

While the terms “operating margin” and “effective tax rate” are not considered U.S. GAAP financial measures, for purposes of this table, we derive the reported (GAAP) measures based on GAAP results, which serve as the basis for the reconciliation to their comparable non-GAAP financial measure.

(2)

The definitions of non-GAAP financial measures used are as follows:

Adjusted Operating Income is defined as Operating Income (as reported in the Condensed Consolidated Statements of Income), excluding income and expenses that are not directly related to the Company’s operating performance during the periods presented.

Adjusted Operating Margin is defined as Adjusted Operating Income (as defined above) expressed as a percentage of Net sales (as reported in the Condensed Consolidated Statements of Income).

Adjusted Net Income attributable to Amphenol Corporation is defined as Net Income attributable to Amphenol Corporation (as reported in the Condensed Consolidated Statements of Income), excluding income and expenses and their specific tax effects that are not directly related to the Company’s operating performance during the periods presented.

Adjusted Effective Tax Rate is defined as Provision for income taxes (as reported in the Condensed Consolidated Statements of Income) expressed as a percentage of Income before income taxes (as reported in the Condensed Consolidated Statements of Income), each excluding the income and expenses and their specific tax effects that are not directly related to the Company’s operating performance during the periods presented.

Adjusted Diluted EPS is defined as diluted earnings per share (as reported in accordance with U.S. GAAP), excluding income and expenses and their specific tax effects that are not directly related to the Company’s operating performance during the periods presented. Adjusted Diluted EPS is calculated as Adjusted Net Income attributable to Amphenol Corporation, as defined above, divided by the weighted average outstanding diluted shares (as reported in the Condensed Consolidated Statements of Income).

AMPHENOL CORPORATION

SUPPLEMENTAL FINANCIAL INFORMATION

RECONCILIATIONS OF GAAP TO NON-GAAP FINANCIAL MEASURES – GUIDANCE

(Unaudited)

(dollars in millions, except per share data)

Management utilizes the non-GAAP financial measures defined earlier as part of its internal reviews for purposes of monitoring, evaluating and forecasting the Company’s financial performance, communicating operating results to the Company’s Board of Directors and assessing related employee compensation measures. Management believes that such non-GAAP financial measures may be helpful to investors in assessing the Company’s overall financial performance, trends and period-over-period comparative results. Adjusted Diluted EPS, a non-GAAP financial measure, excludes income and expenses that are not directly related to the Company’s operating performance during the periods presented. Items excluded in the presentation of this non-GAAP financial measure in any period may consist of, without limitation, acquisition-related expenses, refinancing-related costs, and certain discrete tax items including but not limited to (i) the excess tax benefits related to stock-based compensation and (ii) the impact of significant changes in tax law. Adjusted Diluted EPS is not necessarily the same or comparable to similar measures presented by other companies, as such measures may be calculated differently or may exclude different items. Such non-GAAP financial measure should be read in conjunction with the Company’s financial statements presented in accordance with U.S. GAAP.

The Company excludes the above items in its guidance for the upcoming quarter only to the extent that the Company reasonably expects to record such items in the forward-looking period presented and such amounts are estimable. As the Company has not yet identified any such items for the forward-looking period presented, there are currently no reconciling items for the three months ended September 30, 2020.

Spread the word

Discuss

This site uses Akismet to reduce spam. Learn how your comment data is processed.